AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 38 filers reported holding AIM IMMUNOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,525 | -47.6% | 36,950 | 0.0% | 0.00% | – |
| Q3 2022 | $22,000 | -24.1% | 36,950 | -1.3% | 0.00% | – |
| Q2 2022 | $29,000 | -35.6% | 37,450 | -22.7% | 0.00% | – |
| Q4 2021 | $45,000 | -54.1% | 48,450 | 0.0% | 0.00% | – |
| Q3 2021 | $98,000 | -4.9% | 48,450 | +1.0% | 0.00% | – |
| Q2 2021 | $103,000 | – | 47,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |